How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare unfractionated heparin (UFH) and bivalirudin in the
performance and subsequent outcomes of Primary percutaneous coronary intervention. This will
be a pragmatic trial. Interventional procedures will be performed to reflect current and
evolving standards, including predominant radial access. All patients will be treated with
routine oral anti-platelet therapy pre-procedure. GP IIb/IIIa inhibitors will be reserved for
'bail out' treatment only.
Phase:
Phase 4
Details
Lead Sponsor:
Liverpool Heart and Chest Hospital NHS Foundation Trust